NEWARK, Del, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global fructosamine test market was valued at around US$ 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period.

Fructosamine testing is used to monitor a person’s blood glucose level if they have diabetes mellitus. It is also useful in determining the efficacy of changes in one’s diabetic treatment plan, such ...

The global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total market valuation is expected ...

Please provide your email address to receive an email when new articles are posted on . Fructosamine can be a good glycemia screening tool and elevated levels can have a predictive role for ...

Imagine your body whispering warnings long before you feel anything wrong but unless you listen carefully, those whispers go unheard. For many people today, that whisper is a subtle blood-sugar ...